Figure 4From: The efficacy of incretin therapy in patients with type 2 diabetes undergoing hemodialysisDuration of hyperglycemia (A) and hypoglycemia (B). Data are presented as mean ± SEM, *p < 0.05, n = 10, Ins; insulin, Lira; once-daily injection of 0.3 mg liraglutide, Vilda; once-daily oral administration of 50 mg vildagliptin, Alo; once-daily oral administration of 6.25 mg alogliptin.Back to article page